Requirements for medications commonly used in the treatment of allergic rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) allergic rhinitis and its impact on asthma (ARIA)
- Author
- J BOUSQUET, Paul Van Cauwenberge (UGent) , Claus Bachert (UGent) , GW CANONICA, P DEMOLY, SR DURHAM, W FOKKENS, R LOCKEY, EO MELTZER, J MULLOL, RM NACLERIO, D PRICE, FER SIMONS, AM VIGNOLA and JO WARNER
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-285160
- MLA
- BOUSQUET, J., et al. “Requirements for Medications Commonly Used in the Treatment of Allergic Rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) Allergic Rhinitis and Its Impact on Asthma (ARIA).” ALLERGY, vol. 58, no. 3, BLACKWELL MUNKSGAARD, 2003, pp. 192–97.
- APA
- BOUSQUET, J., Van Cauwenberge, P., Bachert, C., CANONICA, G., DEMOLY, P., DURHAM, S., … WARNER, J. (2003). Requirements for medications commonly used in the treatment of allergic rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) allergic rhinitis and its impact on asthma (ARIA). ALLERGY, 58(3), 192–197.
- Chicago author-date
- BOUSQUET, J, Paul Van Cauwenberge, Claus Bachert, GW CANONICA, P DEMOLY, SR DURHAM, W FOKKENS, et al. 2003. “Requirements for Medications Commonly Used in the Treatment of Allergic Rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) Allergic Rhinitis and Its Impact on Asthma (ARIA).” ALLERGY 58 (3): 192–97.
- Chicago author-date (all authors)
- BOUSQUET, J, Paul Van Cauwenberge, Claus Bachert, GW CANONICA, P DEMOLY, SR DURHAM, W FOKKENS, R LOCKEY, EO MELTZER, J MULLOL, RM NACLERIO, D PRICE, FER SIMONS, AM VIGNOLA, and JO WARNER. 2003. “Requirements for Medications Commonly Used in the Treatment of Allergic Rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) Allergic Rhinitis and Its Impact on Asthma (ARIA).” ALLERGY 58 (3): 192–197.
- Vancouver
- 1.BOUSQUET J, Van Cauwenberge P, Bachert C, CANONICA G, DEMOLY P, DURHAM S, et al. Requirements for medications commonly used in the treatment of allergic rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) allergic rhinitis and its impact on asthma (ARIA). ALLERGY. 2003;58(3):192–7.
- IEEE
- [1]J. BOUSQUET et al., “Requirements for medications commonly used in the treatment of allergic rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) allergic rhinitis and its impact on asthma (ARIA),” ALLERGY, vol. 58, no. 3, pp. 192–197, 2003.
@article{285160, author = {{BOUSQUET, J and Van Cauwenberge, Paul and Bachert, Claus and CANONICA, GW and DEMOLY, P and DURHAM, SR and FOKKENS, W and LOCKEY, R and MELTZER, EO and MULLOL, J and NACLERIO, RM and PRICE, D and SIMONS, FER and VIGNOLA, AM and WARNER, JO}}, issn = {{0105-4538}}, journal = {{ALLERGY}}, language = {{eng}}, number = {{3}}, pages = {{192--197}}, publisher = {{BLACKWELL MUNKSGAARD}}, title = {{Requirements for medications commonly used in the treatment of allergic rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) allergic rhinitis and its impact on asthma (ARIA)}}, volume = {{58}}, year = {{2003}}, }